Spero Therapeutics Stock Market Value
| SPRO Stock | USD 0.78 0.03 4.00% |
| Symbol | Spero |
Spero Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share 0.08 | Revenue Per Share | Quarterly Revenue Growth (0.47) | Return On Assets |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Spero Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spero Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spero Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Spero Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Spero Therapeutics or generate 0.0% return on investment in Spero Therapeutics over 90 days. Spero Therapeutics is related to or competes with Assembly Biosciences, Achilles Therapeutics, Instil Bio, CytomX Therapeutics, NextCure, and Nuvation Bio. Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercial... More
Spero Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spero Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spero Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 21.98 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 4.85 |
Spero Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spero Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spero Therapeutics' standard deviation. In reality, there are many statistical measures that can use Spero Therapeutics historical prices to predict the future Spero Therapeutics' volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | (1.32) |
Spero Therapeutics Backtested Returns
Spero Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Spero Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spero Therapeutics' Coefficient Of Variation of (715.51), variance of 14.99, and Risk Adjusted Performance of (0.11) to confirm the risk estimate we provide. The entity has a beta of 0.42, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Spero Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Spero Therapeutics is expected to be smaller as well. At this point, Spero Therapeutics has a negative expected return of -0.44%. Please make sure to validate Spero Therapeutics' coefficient of variation, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to decide if Spero Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.58 |
Modest predictability
Spero Therapeutics has modest predictability. Overlapping area represents the amount of predictability between Spero Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spero Therapeutics price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Spero Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Spero Therapeutics lagged returns against current returns
Autocorrelation, which is Spero Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Spero Therapeutics' stock expected returns. We can calculate the autocorrelation of Spero Therapeutics returns to help us make a trade decision. For example, suppose you find that Spero Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Spero Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Spero Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Spero Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Spero Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Spero Therapeutics Lagged Returns
When evaluating Spero Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Spero Therapeutics stock have on its future price. Spero Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Spero Therapeutics autocorrelation shows the relationship between Spero Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Spero Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Spero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Spero Stock
Moving against Spero Stock
| 0.68 | ETON | Eton Pharmaceuticals | PairCorr |
| 0.6 | LLY | Eli Lilly | PairCorr |
| 0.58 | VIGL | Vigil Neuroscience | PairCorr |
| 0.55 | IVA | Inventiva Sa | PairCorr |
| 0.45 | MGTX | MeiraGTx Holdings PLC Downward Rally | PairCorr |
The ability to find closely correlated positions to Spero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spero Therapeutics to buy it.
The correlation of Spero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Spero Therapeutics Correlation, Spero Therapeutics Volatility and Spero Therapeutics Alpha and Beta module to complement your research on Spero Therapeutics. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Spero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.